This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge
Clinical trial NCT00445510 · COMPLETED
Trial details
- NCT number
- NCT00445510
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.